Cordarone tablet contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Amiodarone}} {{CMG}}; {{AE}} {{AZ}} ==Contraindications== Cordarone is contraindicated in patients with cardiogenic shock; severe sinus-node dysfunction, caus...") |
Ahmed Zaghw (talk | contribs) |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Amiodarone}} | |||
{{CMG}}; {{AE}} {{AZ}} | |||
__NOTOC__ | __NOTOC__ | ||
{{Amiodarone}} | {{Amiodarone}} | ||
| Line 4: | Line 8: | ||
==Contraindications== | ==Contraindications== | ||
Cordarone is contraindicated in patients with [[cardiogenic shock]]; severe sinus-node dysfunction, causing marked sinus bradycardia; second- or third-degree [[atrioventricular block]]; and when episodes of [[bradycardia]] have caused [[syncope]] (except when used in conjunction with a pacemaker). | Cordarone is contraindicated in patients with [[cardiogenic shock]]; severe sinus-node dysfunction, causing marked [[sinus bradycardia]]; second- or third-degree [[atrioventricular block]]; and when episodes of [[bradycardia]] have caused [[syncope]] (except when used in conjunction with a pacemaker). | ||
Cordarone is contraindicated in patients with a known [[hypersensitivity]] to the drug or to any of its components, including iodine.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CORDARONE (AMIODARONE HYDROCHLORIDE) TABLET [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51be39a2-9134-402c-95ad-defe47406ff8 | publisher = | date = | accessdate = }}</ref> | Cordarone is contraindicated in patients with a known [[hypersensitivity]] to the drug or to any of its components, including iodine.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CORDARONE (AMIODARONE HYDROCHLORIDE) TABLET [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51be39a2-9134-402c-95ad-defe47406ff8 | publisher = | date = | accessdate = }}</ref> | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = CORDARONE (AMIODARONE HYDROCHLORIDE) TABLET [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51be39a2-9134-402c-95ad-defe47406ff8 | publisher = | date = | accessdate = }}</ref> | |||
==References== | |||
{{Reflist}} | |||
{{FDA}} | |||
[[Category:Drugs]] | |||
{{Reflist|2}} | |||
[[Category:Drugs]] | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 12:01, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [4]
Contraindications
Cordarone is contraindicated in patients with cardiogenic shock; severe sinus-node dysfunction, causing marked sinus bradycardia; second- or third-degree atrioventricular block; and when episodes of bradycardia have caused syncope (except when used in conjunction with a pacemaker).
Cordarone is contraindicated in patients with a known hypersensitivity to the drug or to any of its components, including iodine.[1] [1]
References
Adapted from the FDA Package Insert.
References
Adapted from the FDA Package Insert.